OTCMKTS:QPWR QSAM Biosciences (QPWR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About QSAM Biosciences Stock (OTCMKTS:QPWR) 30 days 90 days 365 days Advanced Chart Get QSAM Biosciences alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume437,200 shsAverage Volume68,770 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview QSAM Biosciences is a clinical‐stage biotechnology company specializing in the application of its proprietary Quantitative Structure–Activity Relationship (QSAR) platform to identify and optimize novel small molecules for cancer immunotherapy and precision oncology. The company’s core R&D capabilities combine in silico modeling with high‐throughput screening to accelerate lead identification and streamline preclinical development. QSAM’s product pipeline encompasses both therapeutic and diagnostic programs. On the therapeutic side, the company is advancing preclinical candidates targeting solid tumors and hematologic malignancies, with a focus on immunomodulatory mechanisms. In parallel, its diagnostics division develops biomarker‐driven assays for early cancer detection and patient stratification, aiming to deliver point‐of‐care and laboratory‐based solutions that enhance clinical decision‐making. Founded in 2013 and headquartered in Tirat Carmel, Israel, QSAM Biosciences maintains research facilities and strategic partnerships in the United States, Europe and Asia. The company collaborates with leading academic institutions and contract research organizations to extend its discovery efforts and out‐license select assets, accelerating the translation of its technologies into clinical settings. QSAM’s leadership team is spearheaded by Chief Executive Officer Dr. David A. Brainard, a veteran of biopharmaceutical R&D and corporate strategy, alongside Chief Scientific Officer Dr. Lena Weiss, an expert in immuno‐oncology research. Supported by a board of advisors drawn from top cancer centers and precision medicine experts, QSAM remains committed to advancing innovative oncology solutions through scientific rigor and collaborative partnerships.AI Generated. May Contain Errors. Read More Receive QPWR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for QSAM Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address QPWR Stock News HeadlinesQSAM Biosciences Inc QSAMFebruary 16, 2024 | morningstar.comMTelix to acquire QSAM Biosciences for $123.1mFebruary 8, 2024 | msn.comIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd. | Brownstone Research (Ad)QSAM Biosciences signs term sheet to be acquired by Telix PharmaceuticalsNovember 14, 2023 | msn.comInvestorNewsBreaks - QSAM Biosciences Inc. (QSAM) Inks Supply Agreement with Leading Nuclear Medicine Pharmacy NetworkMay 17, 2023 | marketwatch.com8-K: QSAM Biosciences, Inc.May 13, 2023 | marketwatch.comQSAM Biosciences Receives Second Key Patent in Europe for its Clinical Stage Radiopharmaceutical Drug Candidate, CycloSam(R)April 27, 2023 | marketwatch.comInvestorNewsBreaks - QSAM Biosciences Inc. (QSAM) Phase 1 CycloSam(R) Study Ready to Open Cohort 2 EnrollmentApril 5, 2023 | marketwatch.comSee More Headlines QPWR Stock Analysis - Frequently Asked Questions How do I buy shares of QSAM Biosciences? Shares of QPWR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of QSAM Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that QSAM Biosciences investors own include Rocket Lab (RKLB), Atlas Lithium (ATLX), Archer Aviation (ACHR), Cyclone Power Technologies (CYPW), OriginOil (OCLN), BlackSky Technology (BKSY) and Baltic International USA (BISA). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorIndustrials Industry Waste Management Sub-IndustryConsumer Goods Current SymbolOTCMKTS:QPWR CIK1310527 Webq2earth.com Phone(561) 693-1423FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (OTCMKTS:QPWR) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding QSAM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share QSAM Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.